Delivery Order 75N93021D00007-75N93021F00002
Award Date 4/15/21
Potential Completion Date 8/14/21
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Preclinical Services for HIV Therapeutics master IDIQ contract funds the guaranteed minimum amount of $0.00 to Lovelace Biomedical and Environmental Research Institute, Inc. for preclinical services supporting HIV therapeutics research. Performance will occur in Albuquerque, New Mexico. The prime contractor, Lovelace Biomedical and...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Lovelace Biomedical Research Institute on May 30, 2017, with a ceiling value of $8,558.13, under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ for development of a quality assurance and quality control plan for activities conducted under Task Area C. Place of performance is Albuquerque, NM. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of May 31, 2018. No...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,168 delivery order to Lovelace Biomedical Research Institute under the Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity master contract. Lovelace will perform guaranteed minimum work related to advancing pediatrics and HIV prevention science from April 2023 through June 2024 in Albuquerque, New Mexico. The...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order contract to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization based in Albuquerque, New Mexico, to perform transfer, validation, and qualification of bioanalytical methods for detection of cabotegravir and levonorgestrel in rat and nonhuman primate plasma. The contract, valued at $680,219.00, carries a cost-plus fixed fee pricing structure with an...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $481,814.66 contract is for the transfer and validation of a bioanalytical method to detect cabotegravir, a candidate HIV treatment, in rat plasma. This work is being conducted under NIAID's Comprehensive Resources for HIV...
- This is a $385,704.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the characterization of spontaneous osteogenesis, or bone formation, after surgical segmental bone defect in a large animal model. The work will take place in...
- This delivery order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Nebraska Medical Center under the Preclinical Services for HIV Therapeutics master IDIQ contract. The $13,328.86 order is for the development and delivery of a quality assurance/quality control plan and participation in a task order initiation meeting to support the NIH's work in HIV/AIDS therapeutics research. Performance will take place in Omaha,...
- This federal contract award is for a Delivery Order under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $1,513,255.77 cost-plus-fixed-fee contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, to provide a non-human primate model for testing the immunogenicity and...
- <p>The Lovelace Biomedical Research Institute has been awarded a $3,720,750.00 delivery order contract from the National Institutes of Health National Center for Advancing Translational Sciences to conduct efficacy and safety evaluations of lead gene therapy candidates in neuromuscular junction disease mouse models and develop bioanalytical assay methods. The cost plus fixed fee contract will be performed in Albuquerque, New Mexico over a three year period ending September 2026.</p>